secwatch.observer — SEC 8-K summary
======================================

Issuer:     NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)
CIK:        0000787253
Form:       8-K
Filed at:   2022-02-10T23:59:59+00:00
Accession:  0001437749-22-002917
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NAI Q2 FY2022 net sales down 21.5% YoY to $37.7M; diluted EPS $0.30 vs $0.57
----------------------------------------------------------------------------

- Net income $1.8M ($0.30 diluted EPS) vs $3.6M ($0.57) in prior-year quarter; private-label sales fell 25.7% to $33.7M.
- Sales to largest customer dropped 48%; CarnoSyn beta-alanine revenue up 46.9% to $4.1M; backlog exceeded $12M due to supply chain issues.
- FY2022 guidance: net sales flat to slightly up vs FY2021; H2 net sales expected to increase 10%-13% YoY; operating margin 8%-11%.
- Cash and equivalents $19.4M; $20.0M available under credit line; new blending capacity online in Vista, CA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/787253/000143774922002917/0001437749-22-002917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/787253/000143774922002917/naii20220209_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-002917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer